Gelonghui, May 16, 丨 China Resources Pharmaceutical (03320.HK) issued an announcement. On May 15, 2024, China Resources 39 (an indirect non-wholly-owned subsidiary of the company) and China Resources Electric Power signed a cooperation agreement on proposed cooperation related to new energy projects. The period starts on May 15, 2024 and ends on December 31, 2024. According to the cooperation agreement, China Resources 39 and China Resources Electric Power have agreed to cooperate with each other on new energy power generation projects (“new energy projects”) for “medicinal photovoltaic complementary” photovoltaic power generation projects and other new energy projects for which development rights have already been obtained, in the following manner.
It is expected that the proposed cooperation with China Resources Electric Power Group on new energy projects will help improve the Group's layout in the Chinese medicine industry chain, enhance the Group's core capabilities in the upstream Chinese medicine industry chain, and further strengthen the Group's sustainable development capacity and market competitiveness in the Chinese medicine industry chain by grasping the local Chinese herbal medicine production area layout and superior resources, which is consistent with the Group's development plan in the Chinese medicine industry chain.